Psilocybin-Assisted Therapy for Prolonged Grief
The primary purpose of this study is to explore the feasibility of conducting a clinical trial on the effects of psilocybin for individuals with prolonged grief disorder (PGD).
- Status
- recruiting
- Phase
- Early Phase 1
- Institution
- University of Virginia
- Principal investigator
- Jennifer K Penberthy, PhD
- Start date
- 2026-03-24
- End date
- 2027-08-01
- Registry ID
- NCT06724289
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.